Stock Events

Stock Events

Cocrystal Pharma 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q1 2026
Q2 2026
Next
-0.2
-0.17
-0.15
-0.12
Expected EPS
-0.12042800000000001
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-7.68MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 8CC1.MU. It's not an investment recommendation.
Microsoft
10
MSFT
Apple
9
AAPL
Bionano Genomics
9
BNGO
Tesla
8
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is a leading biopharmaceutical company that competes with Cocrystal Pharma in the development of antiviral drugs, including treatments for hepatitis C and influenza.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. is a global healthcare company that develops antiviral drugs and vaccines, directly competing with Cocrystal Pharma's focus on novel antiviral therapies.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories operates in the healthcare sector, developing diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals, including antivirals that compete with Cocrystal Pharma.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. is a research-based global biopharmaceutical company. It competes with Cocrystal Pharma in the development and commercialization of antiviral drugs.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines, including antivirals, which puts it in competition with Cocrystal Pharma.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals is known for its focus on creating new possibilities in medicine to cure diseases and improve people's lives, including the development of antiviral drugs that compete with Cocrystal Pharma.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that develops and commercializes medicines for the treatment of serious medical conditions, including antiviral therapies that compete with Cocrystal Pharma.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson is a comprehensive healthcare company that develops pharmaceuticals, including antiviral drugs, competing with Cocrystal Pharma's research and development focus.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including antivirals, competing with Cocrystal Pharma.
Novartis
NVS
Mkt Cap292.35B
Novartis AG is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide, including antiviral drugs that compete with Cocrystal Pharma.

About

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
Show more...
CEO
James E. Sapirstein
Employees
10
Country
United States
ISIN
US19188J3005
WKN
000A3DWYX

Listings

STU
DE
8CC.STU
MU
DE
8CC1.MU
MU
DE
8CC.MU
XNAS
US
COCP

0 Comments

Share your thoughts

FAQ

What is Cocrystal Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Cocrystal Pharma stocks are traded under the ticker 8CC1.MU.
When is the next Cocrystal Pharma earnings date?▼
Cocrystal Pharma is going to release the next earnings report on November 16, 2026.
What were Cocrystal Pharma earnings last quarter?▼
8CC1.MU earnings for the last quarter are -0.2 EUR per share, whereas the estimation was -0.14 EUR resulting in a -39.39% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Cocrystal Pharma revenue for the last year?▼
Cocrystal Pharma revenue for the last year amounts to 0 EUR.
What is Cocrystal Pharma net income for the last year?▼
8CC1.MU net income for the last year is -7.68M EUR.
How many employees does Cocrystal Pharma have?▼
As of September 04, 2026, the company has 10 employees.
In which sector is Cocrystal Pharma located?▼
Cocrystal Pharma operates in the Health & Wellness sector.
When did Cocrystal Pharma complete a stock split?▼
The last stock split for Cocrystal Pharma was on October 11, 2022 with a ratio of 1:12.
Where is Cocrystal Pharma headquartered?▼
Cocrystal Pharma is headquartered in BOTHELL, United States.